Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Jan 9;34(2):542–559. doi: 10.1007/s12325-016-0467-6

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2017

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

PMC Copyright notice

Fig. 2 — Induction and maintenance phase primary endpoints in UC patients by baseline age group. a Clinical response at week 6 in the induction ITT population and b clinical remission at week 52 in the maintenance ITT population. CI confidence interval, ITT intent-to-treat, PBO placebo, UC ulcerative colitis, VDZ vedolizumab. ^aPatients received VDZ during induction and PBO during maintenance. ^bPatients received VDZ during induction and VDZ every 4 weeks or every 8 weeks during maintenance